ProCE Banner Activity

Understanding the Interdependencies of Targeted Pathways: Rationale for PARP Inhibitor Combinations

Slideset Download
Download these slides from a live Webinar to learn about the rationale underlying PARP inhibitor combination therapeutic strategies in metastatic castration-resistant prostate cancer.

Released: June 15, 2021

Expiration: June 14, 2022

Share

Faculty

Joaquin Mateo

Joaquin Mateo, MD, PhD

Medical Oncology Department
Vall d’Hebron University Hospital
Group Leader
Vall d’Hebron Institute of Oncology
Barcelona, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.

Faculty Disclosure

Primary Author

Joaquin Mateo, MD, PhD

Medical Oncology Department
Vall d’Hebron University Hospital
Group Leader
Vall d’Hebron Institute of Oncology
Barcelona, Spain